GlassScriptPhysician profile
Osvaldo Padron
NPI 1720069537
$16,755.09
in general payments reported to CMS, 2019-2025
46 companies · $701 in 2025
The $701 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,339 · 2020: $1,431 · 2021: $3,115 · 2022: $2,294 · 2023: $1,260 · 2024: $6,614 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Food and Beverage: $2,881 · Travel and Lodging: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Food and Beverage | $2,880.54 |
| Travel and Lodging | $294.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,363.21 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Spaceoar Vue System - 10ml |
| Axonics, INC. | $3,334.94 | 2020-2023 | Axonics |
| Bluewind Medical | $535.74 | 2020-2024 | Revi |
| Astellas Pharma US INC | $470.71 | 2019-2024 | Xtandi |
| Abbvie INC. | $417.79 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $387.72 | 2019-2024 | Xiaflex, Edex |
| Janssen Biotech, INC. | $255.02 | 2021-2023 | Tremfya |
| Sumitomo Pharma America, INC. | $249.40 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $238.05 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.27 | 2019-2023 | |
| Endo USA, INC. | $108.72 | 2024-2025 | Xiaflex, Aveed |
| Amgen INC. | $108.59 | 2019-2021 | |
| Myovant Sciences INC. | $105.95 | 2021-2022 | |
| Antares Pharma, INC. | $100.00 | 2023 | Xyosted, Tlando |
| Procept Biorobotics Corporation | $88.25 | 2021-2024 | Aquabeam System |
Show all 39 companies
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osvaldo Padron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.